BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24853230)

  • 1. International adaptation and use of NCCN Guidelines.
    Bazarbachi A; Zelenetz AD
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):838-41. PubMed ID: 24853230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The process of NCCN guidelines adaptation to the Middle East and North Africa region.
    Jazieh AR; Azim HA; McClure J; Jahanzeb M
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S5-7. PubMed ID: 20697132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.
    Abulkhair O; Saghir N; Sedky L; Saadedin A; Elzahwary H; Siddiqui N; Al Saleh M; Geara F; Birido N; Al-Eissa N; Al Sukhun S; Abdulkareem H; Ayoub MM; Deirawan F; Fayaz S; Kandil A; Khatib S; El-Mistiri M; Salem D; Sayd el SH; Jaloudi M; Jahanzeb M; Gradishar WI;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S8-S15. PubMed ID: 20697133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
    Bazarbachi A; Azim HA; Alizadeh H; Aljurf M; Barista I; Chaudhri NA; Fahed Z; Fahmy OA; Ghavamzadeh A; Khalaf MH; Khatib S; Kutoubi A; Paydas S; Elayoubi HR; Zaatari G; Zawam HM; Zelenetz AD;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S29-35. PubMed ID: 20697129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.
    Içli F; Akbulut H; Bazarbashi S; Kuzu MA; Mallath MK; Rasul KI; Strong S; Syed AA; Zorlu F; Engstrom PF;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S22-5. PubMed ID: 20697127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.
    Zelenetz AD
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):797-800. PubMed ID: 24853220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.
    Hassen WA; Karsan FA; Abbas F; Beduk Y; El-Khodary A; Ghosn M; Khader J; Khauli R; Rabah DM; Shamseddine A; Srinivas S;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S26-8. PubMed ID: 20697128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region.
    Shamieh O; Jazieh AR;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S41-7. PubMed ID: 20697131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.
    Jazieh AR; Bamefleh H; Demirkazik A; Gaafar RM; Geara FB; Javaid M; Khader J; Khodadad K; Omar W; Saadeddin A; Sabe HA; Shadmehr MB; El Sherif A; Uddin N; Jahanzeb M; Ettinger D;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S16-21. PubMed ID: 20697125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
    Yusuf MA; Kapoor VK; Kamel RR; Kazmi A; Uddin N; Masood N; Al-Abdulkareem A;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S36-40. PubMed ID: 20697130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International adaptations of NCCN Clinical Practice Guidelines in Oncology.
    Carlson RW; Larsen JK; McClure J; Fitzgerald CL; Venook AP; Benson AB; Anderson BO
    J Natl Compr Canc Netw; 2014 May; 12(5):643-8. PubMed ID: 24812133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New NCCN Guidelines: Smoking Cessation for Patients With Cancer.
    Shields PG
    J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):643-5. PubMed ID: 25995418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium.
    Birkeland ML; McClure JS
    Arch Pathol Lab Med; 2015 May; 139(5):608-11. PubMed ID: 25333835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?
    Ettinger DS; Kuettel M; Malin J; McClure JS; Smith ML; Zelenetz AD; Stewart FM
    J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):640-2. PubMed ID: 25995417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish.
    Guillem V; Camps C; Carrato A; Díaz-Rubio E; Gascón P
    Clin Transl Oncol; 2017 Mar; 19(3):288-290. PubMed ID: 27604422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)?
    Akaza H
    Jpn J Clin Oncol; 2016 Apr; 46(4):299-302. PubMed ID: 26830151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCCN Frameworks for Resource Stratification of NCCN Guidelines: Adult Cancer Pain and Palliative Care.
    Swarm RA; Dans M
    J Natl Compr Canc Netw; 2018 May; 16(5S):628-631. PubMed ID: 29784742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care.
    Carlson RW; Scavone JL; Koh WJ; McClure JS; Greer BE; Kumar R; McMillian NR; Anderson BO
    J Natl Compr Canc Netw; 2016 Aug; 14(8):961-9. PubMed ID: 27496112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
    Zagouri F; Liakou P; Bartsch R; Peccatori FA; Tsigginou A; Dimitrakakis C; Zografos GC; Dimopoulos MA; Azim HA
    Breast; 2015 Aug; 24(4):513-23. PubMed ID: 25818651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.